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Abstract
Background: The biochemical components of saliva can change in certain pathologies in horses, for example in
acute abdominal disease. The aim of this study was (1) to evaluate if a panel of biochemical analytes usually used in
serum can be measured in saliva of horses and (2) to study the possible changes of these biochemical analytes in
saliva of horses affected by acute abdominal disease. A panel of 23 analytes was analytically validated in saliva of
horses and possible changes in these analytes in a pilot study with six healthy horses and six horses with acute
abdominal disease were evaluated. The analytes with significant changes were then evaluated in a larger
population of 20 healthy and 37 diseased horses.
Results: Seven analytes showed significant increases in the pilot study which were confirmed in the larger
population. The analytes which showed significant changes, and their median fold increase and significance shown
in the larger population were salivary γ-glutamyl transferase (gGT, 2.3 fold, P = 0.001), creatine kinase (CK, 6.2 fold,
P < 0.001), urea (2.3 fold, P = 0.001), total bilirubin (2.6 fold,
P < 0.001), total proteins (3.2 fold, P < 0.001), phosphorus (P, 4.5 fold, P < 0.001) and alpha-amylase (sAA, 8.5 fold,
P < 0.001). Total proteins, P and sAA showed sensitivities higher than 70% at their optimal cut-off points and a
specificity of 100% in differentiating between healthy horses and those with acute abdominal disease.
Conclusions: A panel of 23 biochemical analytes can be measured in saliva of horses, where gGT, CK, urea, total
bilirubin, total protein, P and sAA levels are raised in horses with acute abdominal disease.
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Background
Saliva mainly consists of water, which represents up to
99% of its total volume. In addition, studies on human
and veterinary species have reported that saliva also
contains compounds such as phosphorus (P), lactate,
cholesterol, fatty acids, glucose, hormones such as
cortisol, triglycerides, urea and uric acid [1, 2]. In
addition, saliva has enzymes such as salivary alpha-
amylase (sAA), lipase, carbonic anhydrase, adenosine
deaminase (ADA), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase
(ALP), lactate dehydrogenase (LDH) and creatine kinase
(CK), among others [3–8].
The composition of saliva can be affected by systemic dis-
orders [9]. Due to this, there has been increased interest over
recent years in the use of saliva as a diagnostic fluid. In
addition, saliva has some advantages over blood since it is
easily collected by non-invasive, non-stressful procedures
[10, 11] and by non-trained personnel with a minimum of
material. For these reasons, a new term in human medicine,
"sialochemistry", has been created, which consists of the
measurement of analytes included in the routine
serum biochemistry profiles in saliva [12, 13]. In animal spe-
cies, saliva analytes have been studied in different situations.
For example, total esterase (TEA), cholinesterase (ChE) and
ADA increase in pigs affected by an acute stress or by a
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pathologic condition such as lameness [4, 5]. In
horses, sAA and cortisol increase in acute abdominal
disease, acting as possible pain-induced stress bio-
markers [3]. In addition, in a proteomic study [14],
acute phase proteins in saliva were observed to
change in horses with this disease. However, to the
authors’ knowledge, other routine biochemistry ana-
lytes have not been measured in saliva in horses with
acute abdominal disease, so their potential utility as
biomarkers is unknown.
The objective of this paper was to evaluate if a panel
of biochemical analytes usually used in serum can be
measured in saliva of horses, and also to study the
possible changes of these biochemical analytes in saliva
of horses affected by acute abdominal disease. For this
purpose, a pilot exploratory evaluation was first made of
healthy horses and those with acute abdominal disease
to assess possible differences between the two groups of
animals in a profile of 23 biochemical analytes. Then,
those salivary analytes that significantly varied in the




The diseased population (n = 6), diagnosed as having
acute gastrointestinal disease, came from the Veterinary
Teaching Hospital of the University of Extremadura
(Table 1). The diagnosis was based on history, physical
examination, haematology and plasma biochemistry
(Olympus Diagnostica GmbH AU 600, Beckman
Coulter, Ennis, Ireland), transabdominal ultrasonog-
raphy, and response to treatment by a board-certified
internist (MMC). In horses undergoing surgery, the
diagnosis of the acute gastrointestinal disease was based
on laparotomy findings.
The healthy population (n = 6) was composed of
horses admitted for castration or routine health check in
the Veterinary Teaching Hospital of the University of
Extremadura and of privately owned horses from a
stable in the province of Almería (Spain) (Table 1). The
healthy horses showed no clinical signs of abdominal
pain [15] during the physical examination. In addition,
the heart rate (HR) and respiratory rate (RR) were within
normal limits and they had no haematological or
biochemical abnormalities.
Confirmatory study
The diseased population (n = 37), diagnosed as having
acute gastrointestinal disease, came from the Veterinary
Teaching Hospital of the University of Extremadura
between January and October 2018. It was composed of
14 geldings, 14 stallions and 9 mares with 9 ± 4.6 years
of age, including 12 Pure Spanish horses, 11 Crossbreds,
4 Warmbloods breeds, 4 Arabians, 3 Lusitanian horses,
2 Thoroughbreds, and 1 Friesian horse. The diagnosis
was performed as in the pilot study and included enter-
itis (n = 8), strangulating lesion in the small intestine
(n = 7), impaction of the pelvic flexure (n = 5), large
colon displacement (n = 4), impaction of the right dorsal
colon (n = 3), colitis (n = 3), large colon volvulus (n = 2),
cecal tympany (n = 1), gastric perforation (n = 1), impac-
tion of the small colon (n = 1), gastric ulcer syndrome
(n = 1) and fecaloma in the small colon (n = 1).
The healthy population (n = 20) was selected as in the
pilot study. It included 8 stallions, 6 females and 6
geldings, with an average age of 9 ± 4.4 years. The breeds
included 14 Pure Spanish horses, 4 Crossbreds, 1
Arabian and 1 Thoroughbred.
Sampling
Saliva samples were obtained in the diseased population
within 30 min of arrival at the hospital once horses were
Table 1 Overview of horses included in the pilot exploratory study
Group Age (year) Gender Breed Diagnosis
Diseased horses 23 Stallion Pure Spanish horse Enteritis
4 Mare Crossbred Impaction of the pelvic flexure
8 Stallion Arabian Impaction of the right dorsal colon
5 Stallion Pure Spanish horse Strangulated lesion in the small intestine
10 Mare Crossbred Fecaloma with ischemia
7 Gelding Crossbred Large colon displacement
Healthy horses 5 Stallion Pure Spanish horse Healthy horse
5 Stallion Pure Spanish horse Healthy horse
15 Gelding Pure Spanish horse Healthy horse
13 Gelding Crossbred Healthy horse
14 Mare Crossbred Healthy horse
4 Mare Pure Spanish horse Healthy horse
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in their box stalls. Upon arrival at the hospital, saliva
samples were obtained prior to clinical examination or
treatment. Saliva was collected by introducing a small
sponge (Esponja Marina, La Griega E. Koronis, Madrid,
Spain) into the horse’s mouth toward the side of the
cheeks, allowing the sponge to be chewed until it was
soaked with saliva. The entire procedures took around 1
min. Then, sponge was placed in collection devices
(Salivette, Sarstedt, Aktiengesellschaft & Co, Nümbrecht,
Germany) and was proceessed as previously reported
[16]. Blood samples were collected just after saliva sam-
pling by jugular venipuncture and transferred into
lithium-heparin tubes (Li Heparin, Aquisel®, Barcelona,
Spain). Horses that yielded plasma samples with gross
haemolysis and blood-contaminated saliva samples
were excluded from the study. Horses with increased
digital pulses or evident lameness were excluded in
order to avoid clinical cases combined with laminitis
or musculoskeletal problems (Additional file 1). Infor-
mation about HR, RR and rectal temperature were
also obtained from the diseased and healthy
populations.
Plasma and saliva biochemistry profile
The chemistry profile measured in plasma was inte-
grated by:
 Enzymes: AST, ALP, γ-glutamyl transferase (gGT),
lipase, amylase, LDH, CK, butyrilcholinesterase
(BChE) and ADA.
 Metabolites: creatinine, urea, uric acid, total
bilirubin, cholesterol, triglycerides, glucose and
lactate.
 Proteins: total proteins, albumin, serum amyloid A
(SAA) and Haptoblobin (Hp).
 Minerals: P and total calcium.
These assays were carried out on an automated
chemistry analyser (Olympus Diagnostica GmbH AU
600), using commercial kits from Beckman (Beckman
Coulter Inc., Fullerton, CA, USA) for all assays with the
exception of ADA, which was measured with a Diazyme
kit (ADA-D assay kit, Diazyme Laboratories, Poway, CA,
USA), and BChE, which was measured according to a
previously reported assay [17]. All these assays showed
low inter and intra-assay imprecision (< 10%) and
high linearity under dilution (R2 > 0.995) in serum.
The same chemistry profile, methods and apparatus
were also used in saliva samples, with the exception of
two analytes in which the analytical method was
different: total proteins, which was evaluated using a
commercial colorimetric kit to measure urine and Low-
Complexity Region (LCR) proteins (protein in urine and
CSF, Spinreact, Spain), and BChE, which was measured
following a previously described method [6]. In addition,
two new analytes were measured in saliva samples: TEA
activity, which was measured using a previously de-
scribed method [5] in the Olympus chemistry analyser,
and cortisol, which was analysed with a solid-phase
competitive enzyme-amplified chemiluminescent im-
munoassay by the immunoassay system (Immulite 1000,
Siemens Healthcare Diagnostic, Deerfields, IL) and
validated in saliva by Escribano et al. [18]. The analytes
in saliva were validated by the researchers’ laboratory,
showing an inter- and intra-variability lower than 10% of
coefficient of variation (CV) and were linear when
applied to serial sample dilutions (R2 = 0.992 ± 0.004)
(Additional file 2). SAA and Hp could not be detected in
saliva with the assays used in plasma (LZ SAA, Eiken
Chemical Co.; and Haptoglobin turbidimetry, Spinreact,
Spain, respectively). Therefore, they were excluded from
the saliva evaluation. SAA and Hp assays used anti-
human serum antibodies. The SAA assay used has been
demonstrated to have cross-reactivity and adequate ac-
curacy for SAA measurement in horses’ plasma [19, 20],
and the antibodies used in the assay for Hp measure-
ment have cross-reactivity with plasma Hp in horse by
western blot (data no showed), similarly to other human
antibodies that showed cross-reactivity with Hp of
horses [21].
Severity scale
The severity of the acute abdominal disease was assessed
using the systemic inflammatory response syndrome
(SIRS) score developed by Roy et al. [22], since it is easy
to apply and because it has been demonstrated in a large
population to be closely associated with the risk of
death, mainly in cases of acute gastrointestinal illness
cases. It was calculated as the sum of abnormal results
in HR (> 52 beats/min), RR (> 20 breaths /min), white
blood cell (WBC) count (above or below 5.0–12.5 × 109/L)
and temperature (below or above 37.0–38.5 °C). Horses
were considered to have SIRS when the score was equal to
or higher than 2 (4-point-score).
Statistical analysis
To evaluate if there were significant differences in the
analytes evaluated in saliva between the healthy and
diseased populations in the pilot exploratory study, an
unpaired Student’s t test (2-tailed) was performed.
Previously, the values were transformed by log applying
the formula ln x = ln (x + 1) [23], since all showed non-
normal distribution when checked using the Shapiro-
Wilk test. The analytes that showed significant changes
were studied in the confirmatory population using the
statistical analysis described above. A stand-alone power
program for statistical testing (G-Power) [24] was
employed using the means and standard deviations of
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the selected analytes initially calculated in the pilot
exploratory study, to establish the minimum number of
individuals necessary to be included in the confirmatory
study in each group for reaching a significance level of
α = 5% (P < 0.05) and a power of 80%. Additionally, a
post hoc analysis was performed with the number of in-
dividuals used in the confirmatory study to guarantee
that the significance level and power required were
correctly obtained.
Spearman correlation was performed on the analytes
of the confirmatory study, in order to evaluate a correl-
ation between them in saliva and plasma, and between
the SIRS score. An r value from 0.90 to 1 was considered
to have very high correlation, 0.70 to 0.90 high correl-
ation, 0.50 to 0.70 moderate correlation, 0.30 to 0.50 low
correlation and less than 0.30 little if any correlation
[25]. A receiver operator characteristic (ROC) curve
analysis was also performed to obtain the optimal cut-off
point to maximise sensitivity and specificity for deter-
mining the healthy and diseased population with acute
abdominal disease. All statistical analyses were performed
using a spreadsheet (Excel 2000, Microsoft Corporation,
Redmond, Washington, USA) and the commercial
statistics package Graph Pad Prism 6 (GraphPad Software
Inc., La Jolla, CA, USA). Values of P ≤ 0.05 were selected
to indicate significance in all analyses.
Results
Differences in salivary analytes between diseased and
healthy populations
Medians and interquartile ranges (IQR) from all the
analytes evaluated in the pilot exploratory study are
shown in Table 2. There were seven analytes that
showed a significant increase in horses with acute ab-
dominal disease compared to healthy horses: gGT
(showing a 1.8 difference between log means, 95% confi-
dence interval [CI] 0.6–3.0, P = 0.008), CK (1.5 difference
between log means, 95% CI 0.1–2.9, P = 0.04), urea (0.9
difference between log means, 95% CI 0.2–1.6, P = 0.02),
total bilirubin (0.2 difference between log means, 95% CI
Table 2 Medians, interquartile ranges (IQR, 25–75%), minimal (Min) and maximal (Max) and values of a biochemical analysis
performed in saliva from 6 healthy horses and 6 horses diagnosed with acute abdominal disease
Healthy horses (n = 6) Diseased horses (n = 6)
Median Min Max IQC Median Min Max IQC
AST (IU/L) 101.8 45.5 205.8 47.8–146.3 212.8 28.1 1216.9 68.5–615.7
ALP (IU/L) 58.5 1.0 79.8 30.3–74.4 131.6 48.0 355.7 48.9–198.2
gGT (IU/L) 31.1 2.5 62.8 19.3–51.8 199.5** 55.9 359.0 65.9–331.5
Lipase (IU/L) 49.8 10.0 100.1 13.23–75.3 26.4 6.7 91.6 16.3–76.8
LDH (IU/L) 270.7 0.0 1195.0 41.9–662.3 688.6 42.3 2896.0 43.9–1795.0
CK (IU/L) 11.1 0.0 23.5 2.4–15.4 30.1* 7.0 140.7 13.5–88.9
BChE (nmol/mL/min) 19.2 5.6 31.1 12.1–27.5 18.6 12.5 62.1 13.6–57.7
ADA (IU/L) 14.5 8.2 85.2 12.4–36.2 41.1 11.8 216.3 26.9–111.6
Creatinine (μmol/L) 28.3 8.8 285.5 13.3–114.0 33.6 0.9 106.1 3.5–64.53
Urea (mmol/L) 7.9 4.1 10.4 5.4–9.7 18.8* 8.2 44.9 9.9–33.7
Uric acid (μmol/L) 59.5 51.8 103.5 52.3–86.8 38.7 0.6 88.6 10.7–71.4
Total bilirubin (μmol/L) 2.9 1.0 10.3 1.7–6.2 7.5* 3.6 13.5 4.3–10.4
Cholesterol (μmol/L) 35.4 0.00 249.8 0.0–169.7 93.4 0.0 263.8 0.00–187.0
Triglycerides (mmol/L) 0.34 0.05 0.68 0.06–0.67 0.21 0.02 3.64 0.04–1.17
Glucose (mmol/L) 0.54 0.01 1.80 0.13–1.05 0.51 0.00 2.99 0.16–2.24
Lactate (mmol/L) 1.73 0.02 3.44 0.42–2.70 0.39 0.01 20.91 0.09–9.32
Total protein (g/L) 1.65 0.96 4.23 1.01–2.72 5.77** 3.47 6.18 3.53–5.99
Albumin (g/L) 0.5 0.1 0.9 0.3–0.8 0.8 0.1 2.6 0.4–1.5
Phosphorus (mmol/L) 0.26 0.04 0.48 0.12–0.34 0.59* 1.20 2.04 0.24–1.72
Calcium (mmol/L) 4.7 4.2 7.0 4.2–7.0 6.4 4.1 9.4 4.8–9.0
sAA (IU/L) 13.5 1.0 23.1 4.2–20.3 109.3** 43.7 544.3 51.7–446.5
Cortisol (μg/dL) 0.93 0.56 1.12 0.79–1.05 0.91 0.6 1.08 0.60–1.02
TEA (IU/L) 141.7 77 165.5 120.7–159.4 133 39.8 184.9 44.2–133.0
AST aspartate aminotransferase, ALP alkaline phosphatase, gGT γ-glutamyl transferase, LDH lactate dehydrogenase, CK creatine kinase, BChE butyrilcholinesterase,
ADA adenosine deaminase, sAA alpha-amylase salivary, TEA total esterase
Asterisk indicates statistically significant differences between groups (*: P < 0.05; **: P < 0.01)
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0.1–0.4, P = 0.05), total protein (1.0 difference between
log means, 95% CI 0.4–1.6, P = 0.004), P (0.6 differ-
ence between log means, 95% CI 0.2–1.3, P = 0.05)
and sAA (2.6 difference between log means, 95% CI
1.3–3.8, P = 0.001).
The power study calculated with the data from the
pilot exploratory study showed that a minimum number
of 11 healthy horses and 21 horses with acute abdominal
disease would be needed to get appropriate results for
the selected analytes. The post hoc analysis performed in
the confirmatory study computed a power 96.4 ± 0.1%
for the gGT, CK, urea, total bilirubin, total protein, P
and sAA results. When these analytes were evaluated in
the study made in the larger population, horses with
acute abdominal disease had values statistically higher
than the healthy ones for all the analytes (Fig. 1).
The optimal cut-off point in saliva for predicting
disease due to acute abdominal disease in the selected
analytes was gGT ≥ 82.7 IU/L (AUC = 0.79; 95% CI:
0.67–0.92; sensitivity 70% [51–85]; specificity 80% [56–
94]), CK ≥ 30.1 IU/L (AUC = 0.85; 95% CI: 0.74–0.95;
sensitivity 64% [45–81]; specificity 100 [83–100]), urea
≥5.3 mmol/L (AUC = 0.79; 95% CI: 0.67–0.92; sensitivity
66% [46–82]; specificity 95% [75–100]), total bilirubin
≥4.4 μmol/L (AUC = 0.73; 95% CI: 0.60–0.86; sensitivity
56% [38–72]; specificity 95% [75–100]), total proteins
≥4.24 g/L (AUC = 0.95; 95% CI: 0.90–1.01; sensitivity
77% [60–90]; specificity 100% [83–100]), P ≥ 0.50
mmol/L (AUC = 0.94; 95% CI: 0.89–1.00; sensitivity
75% [58–88]; specificity 100% [83–100]) and sAA ≥
23.3 IU/L (AUC = 0.92; 95% CI: 0.86–1.00; sensitivity
73% [56–86]; specificity 100% [83–100]).
Correlations
The correlations between the different analytes selected
in saliva, and between these analytes in saliva and
plasma are shown in Table 3. High correlations in saliva
were observed between gGT and urea (r = 0.70, P <
0.001), CK and phosphorus (r = 0.71, P < 0.001) and total
proteins and P (r = 0.75, P < 0.001). Moderate correla-
tions in saliva were observed between gGT and total
proteins (r = 0.67, P < 0.001), P (r = 0.61, P < 0.001) and
CK (r = 0.68, P < 0.001); between CK and total proteins
(r = 0.69, P < 0.001), urea (r = 0.66, P < 0.001), total biliru-
bin (r = 0.57, P < 0.001) and gGT (r = 0.68, P < 0.001);
between urea and total proteins (r = 0.61, P < 0.001) and
P (r = 0.52, P < 0.001); and between total proteins and
sAA (r = 0.61, P < 0.001).
Positive correlations between saliva and plasma
were observed in CK (r = 0.34, P = 0.05), urea (r =
0.49, P = 0.002), total bilirubin (r = 0.37, P = 0.02) and
total proteins (r = 0.34, P = 0.03). The SIRS score
correlated in saliva with CK (r = 0.40, P = 0.03), total
bilirubin (r = 0.41, P = 0.02), total proteins (r = 0.49,
P = 0.003), P (r = 0.50, P = 0.002) and sAA (r = 0.35,
P = 0.05).
Discussion
This report describes for the first time that a profile in-
tegrated by various analytes that are used in routine
serum biochemistry analysis can be measured in saliva
in horses, and that some of these analytes can change in
situations of acute abdominal disease.
In this report, we followed a similar approach that is
made in proteomics studies when changes in a profile of
proteins are studied in a clinical situation [26–28]. First,
an exploratory study in a small population was
performed in order to detect possible analytes that can
change in the situation being studied, in our case acute
abdominal disease. This population, as described in
previous studies, comprised horses with different ages,
sexes, and diagnoses in order to be representative of the
different clinical conditions that can appear in this
disease [14, 29]. Then, the analytes showing changes
were validated in a larger population.
Seven analytes were detected as being raised in saliva
of horses with acute abdominal disease. Two of them
were gGT and total bilirubin, which in serum are associ-
ated with liver dysfunction [30, 31]. Elevations in serum
activity and concentration of both analytes have been as-
sociated with several causes of colic in horses, including
cholelithiasis, infectious colitis, large colon displacement,
ulcerative duodenitis, proximal enteritis and neoplasia
[32]. Total bilirubin in saliva correlated moderately with
plasma; therefore it could be postulated that part of the
bilirubin that appears in saliva comes from plasma. In
addition, total bilirubin was correlated moderately with
the SIRS score, so it could be associated with the
severity of the disease.
CK, which in serum is associated with muscle damage
[33], was raised in our study in the saliva of diseased
horses. Increases in CK in saliva in situations of muscle
damage have been described in dogs [34] and humans
[7] and, therefore, the high values of CK in saliva of
horses with acute abdominal disease could indicate the
existence of muscle damage, which has been described
as occurring in this disease by ischemic injuries [35, 36].
One source of saliva CK could be the CK from
plasma, since significant correlations were found be-
tween CK in plasma and saliva in our study, similarly
to that reported in dogs [34]. In our study, CK in sal-
iva had a significant although low correlation with
SIRS status and therefore it could be an indicator of
the severity of the process.
Increases in serum urea with normal values of creatin-
ine are associated with reduced hydration status [37] or
bleeding in the gastrointestinal tract [38]. Therefore, it
could be postulated that similar causes could produce
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the higher salivary urea found in our study in horses
with acute abdominal disease. A moderate correlation
between urea in saliva and plasma was observed. This
correlation has also been reported in dogs with chronic
kidney disease [39]. The higher concentration of total
proteins observed in saliva in horses with acute
Fig. 1 Results of γ-glutamyl transferase (gGT) (a), creatine kinase (CK) (b), urea (c), total bilirubin (d), total protein (e), phosphorus (f) and salivary
alpha-amylase (sAA) (g) in saliva of a healthy horses population (n = 20) and a diseased horses population (n = 37) with acute abdominal disease.
The plot shows median (line within box), 25th–75th percentiles (box), 5th and 95th percentiles (whiskers) and outliers (•). The cross inside the box
shows the mean. Asterisk indicates statistically significant differences between groups (***: P < 0.001; ****: P < 0.0001)
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abdominal disease could also indicate reduced hydration
status, as it has previously been described in serum [40].
P in serum has been considered a marker of disease
severity and likelihood of mortality in hospitalised foals
[41]. Although in this study P in saliva did not correlate
with P in plasma, it correlated in saliva with the SIRS
score. Further studies should be performed in order to
clarify the undergoing mechanisms of P in saliva.
The increases in sAA activity found in our study on
diseased horses were in agreement with other studies
performed on horses with acute abdominal disease [3,
16]. In addition, a low but significant correlation of sAA
with SIRS status was observed in our study, as previ-
ously reported [3, 16]. The lack of correlation with amyl-
ase in plasma confirms that, as humans, the sAA that
appears in saliva is secreted by the salivary glands [23].
From all the analytes that showed differences between
the horses with acute abdominal disease and the healthy
ones, total proteins, P and sAA showed sensitivities
higher than 70% at their optimal cut-off points and a
specificity of 100% in detecting acute abdominal disease.
Ideally, further studies in which these analytes are evalu-
ated in other diseases should be performed, in order to
evaluate their specificity not only in the case of healthy
individuals but also in individuals with diseases other
than acute abdominal disease.
The power analysis guaranteed adequate statistical
analysis for evaluating differences between healthy and
diseased horses in the confirmatory population. How-
ever, it would be of interest to make future studies in a
larger population to evaluate if changes in analytes could
be related with outcome (survivors vs. non-survivors),
diagnosis (ischaemic/strangulating vs. non-ischaemic/
non-strangulating) and treatment needed (medical
treatment vs. surgery). In addition, it would have been
interesting to include an analysis of electrolytes in saliva
in this study, which was not possible due to volume
constraints.
Conclusions
A panel of 23 analytes can be measured in saliva in
horses, and from these analytes, gGT, CK, urea, total
bilirubin, total protein, phosphorus and sAA can be
raised in horses with acute abdominal disease. Further
studies should be made to evaluate and refine the pos-
sible application of these analytes in clinical situations.
Additional files
Additional file 1: Flow chart describing horses included and excluded
in the diseased populations. Description of horses included or excluded
from the study in the diseased populations. (PDF 225 kb)
Additional file 2: Linearity under dilution in saliva of aspartate
aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transferase
(gGT), lipase, lactate dehydrogenase (LDH), creatine kinase (CK), butyril-
cholinesterase (BChE), adenosine deaminase (ADA), creatinin, urea,
uric acid, total bilirubin, cholesterol, triglycerides, glucose concentration,
total proteins, albumin, lactate, phosphorus (P), calcium and total esterase
(TEA). Linearity under dilution study in three pools of saliva from two
specimen of saliva each. The ‘x’ expressed activity or concentration
measured and ‘y’ expected level at the particular dilution. R2 = coefficient
of determination of linear correlation. (PDF 2190 kb)
Table 3 Spearman correlation coefficients between gGT, CK, urea, total bilirubin, total protein, phosphorus and sAA in saliva and
plasma in healthy (n = 20) and diseased horses (n = 37) with acute abdominal disease
Saliva
gGT (IU/L) CK (IU/L) Urea (mmol/L) Total bilirubin (μmol/L) Total proteins (g/L) Phosphorus (mmol/L) sAA (IU/L)
gGT saliva 0.68*** 0.70*** 0.24 0.67*** 0.61*** 0.26
(IU/L) plasma 0.24 0.15 0.08 0.03 0.41* 0.36* 0.09
CK saliva 0.68*** 0.66*** 0.57*** 0.69*** 0.71*** 0.45**
(IU/L) plasma 0.22 0.34* 0.36* 0.3 0.31 0.34* 0.55***
Urea saliva 0.70*** 0.66*** 0.34* 0.61*** 0.52*** 0.37**
(mmol/L) plasma 0.19 0.24 0.49** 0.36* 0.35* 0.3 0.26
Total bilirubin saliva 0.24 0.57*** 0.34* 0.36** 0.37** 0.49***
(μmol/L) plasma 0.19 0.3 0.08 0.37* 0.51*** 0.60*** 0.39*
Total proteins saliva 0.67*** 0.69*** 0.61*** 0.36** 0.75*** 0.61***
(g/L) plasma 0.32* 0.34* 0.35* 0.18 0.34* 0.29 0.26
Phosphorus saliva 0.61*** 0.71*** 0.52*** 0.37** 0.75*** 0.48***
(mmol/L) plasma 0.06 −0.08 0.07 −0.16 0.18 0.1 0.19
Amylase saliva 0.26 0.45** 0.37** 0.49*** 0.61*** 0.48***
(IU/L) plasma −0.30 −0.24 −0.45* −0.02 0.26 0.14 0.24
Asterisk indicates statistically significant difference between comparisons
gGT γ-glutamyl transferase, CK creatine kinase, sAA salivary alpha-amylase
Asterisk indicates statistically significant correlations (*: P < 0.05; **: P < 0.01; ***: P < 0.001)
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